X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761164
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761164
https://www.fiercepharma.com/special-reports/2022-drug-approvals-after-aduhelm-fiasco-fda-endorsements-were-harder-come
https://www.europeanpharmaceuticalreview.com/news/176622/first-therapy-approved-haemolytic-anaemia-cold-agglutinin-disease/
https://www.sanofi.com/en/media-room/press-releases/2022/2022-11-17-17-50-00-2558583
https://www.ema.europa.eu/en/documents/overview/enjaymo-epar-medicine-overview_en.pdf
https://www.sanofi.com/en/media-room/press-releases/2022/2022-09-16-15-18-01-2517753
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761164
https://www.fiercebiotech.com/biotech/sanofi-s-treatment-for-rare-anemia-hits-goal-second-phase-3
https://endpts.com/sanofi-grapples-with-rejection-of-potential-first-in-class-orphan-drug-faults-third-party-manufacturing/
https://www.pharmiweb.com/press-release/2020-11-16/fda-issues-complete-response-letter-for-sutimlimab-an-investigational-treatment-for-hemolysis-in-adults-with-cold-agglutinin-disease
https://www.reuters.com/article/us-sanofi-products/sanofi-gets-priority-u-s-fda-review-for-sutimlimab-product-idUSKBN22Q0JI?feedType=RSS&feedName=healthNews
Market Place
Share 
